The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Featured Story
The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.
Around 70% of people aged 50-plus receiving HIV care in Latin America in 2015 had an NCD, compared to 32% in the year 2000.
The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested
Peer distribution, youth branding and social media campaigns emerge as top ideas in crowdsourcing contest to improve HIV self-testing among young people.
People living with HIV and TB in South Africa are 2.75 and 2.5 times respectively more likely to die from COVID-19 – but this risk is much lower than for age and diabetes.
World Health Organization changes its position on the wearing of non-medical fabric face masks.
South African study finds that treatment fails in two-thirds of HIV-positive infants, and that failure is linked to concurrent maternal treatment failure.
HIV self-testing recruitment strategies, using social media influencers or community organisations, are both effective, but reach different groups of gay men.
Despite intensified efforts to increase HIV testing in sub-Saharan Africa, poorer and less educated people are still missing out.
Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.
When starting treatment in the third trimester, women taking dolutegravir more likely to achieve undetectable viral loads at the time of giving birth compared with those taking efavirenz.
